Business
My adviser recommended an annuity. Is it the right move in this market environment?
By Katherine Langford
Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
Katherine Langford
Katherine Langford
Editor-in-Chief · Edina, MN
Katherine oversees editorial operations across all six brands. Before joining The Meridan Group, she spent 14 years at the Minneapolis Star Tribune, where she led the metro desk through its digital transformation. She holds a Master's in Journalism from Northwestern's Medill School.
More from Katherine →Editor-in-Chief · Friday, November 6, 2026 at 4:29 PM · 1 min read
As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.
Up nextMy adviser recommended an annuity. Is it the right move in this market environment?Business · 1 min read
More Business stories
Business
I’m 65 and worth more than $5.6 million. Can I afford a $200,000 camper?
By Marcus Chen
Business
DraftKings’ expensive bet on prediction markets is crushing its stock
By Katherine Langford
Business
Two months after my father’s funeral, my stepmother asked me to repay his $40,000 wedding gift. Should I do what she says?
By Marcus Chen